Zealand Pharma A/S (ZLDPF)
34.00
-0.16
(-0.47%)
USD |
OTCM |
Oct 15, 16:00
Zealand Pharma Cash from Operations (TTM) : -241.46M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -241.46M |
| March 31, 2026 | 983.40M |
| December 31, 2025 | 1.018B |
| September 30, 2025 | 1.163B |
| June 30, 2025 | 1.152B |
| March 31, 2025 | -170.16M |
| December 31, 2024 | -132.06M |
| September 30, 2024 | -100.85M |
| June 30, 2024 | -73.81M |
| March 31, 2024 | -66.11M |
| December 31, 2023 | -61.90M |
| September 30, 2023 | -107.82M |
| June 30, 2023 | -108.42M |
| March 31, 2023 | -112.86M |
| December 31, 2022 | -132.31M |
| September 30, 2022 | -137.89M |
| June 30, 2022 | -151.48M |
| March 31, 2022 | -174.43M |
| December 31, 2021 | -186.26M |
| September 30, 2021 | -187.72M |
| June 30, 2021 | -172.48M |
| March 31, 2021 | -134.34M |
| December 31, 2020 | -106.03M |
| September 30, 2020 | -86.45M |
| June 30, 2020 | -93.48M |
| Date | Value |
|---|---|
| March 31, 2020 | -99.55M |
| December 31, 2019 | -60.79M |
| September 30, 2019 | -58.77M |
| June 30, 2019 | -51.92M |
| March 31, 2019 | -48.61M |
| December 31, 2018 | -71.37M |
| September 30, 2018 | -65.42M |
| June 30, 2018 | -51.21M |
| March 31, 2018 | -51.98M |
| December 31, 2017 | -44.10M |
| September 30, 2017 | -10.40M |
| June 30, 2017 | -15.90M |
| March 31, 2017 | -6.826M |
| December 31, 2016 | 6.709M |
| September 30, 2016 | -16.85M |
| June 30, 2016 | -19.05M |
| March 31, 2016 | -18.24M |
| December 31, 2015 | -33.55M |
| September 30, 2015 | -33.01M |
| June 30, 2015 | -22.99M |
| March 31, 2015 | -23.91M |
| December 31, 2014 | -7.206M |
| September 30, 2014 | -9.113M |
| June 30, 2014 | -18.08M |
| March 31, 2014 | -14.99M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Genmab A/S | 891.90M |
| Ascendis Pharma A/S | 405.71M |
| Bavarian Nordic A/S | 221.90M |
| Evaxion AS | -- |
| ACADIA Pharmaceuticals, Inc. | 160.32M |